NCT05481151 2025-08-13A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PVPharmaEssentiaPhase 3 Active not recruiting111 enrolled
NCT01773187 2020-09-29Pacritinib Versus Best Available Therapy to Treat MyelofibrosisCTI BioPharmaPhase 3 Terminated327 enrolled 11 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts